Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) — Capital Reinvestment Ratio
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Capital Reinvestment Ratio of 0.20x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥36.25 Million) in capital expenditures (CN¥7.27 Million). Check Tonghua Golden-Horse Pharmaceutical Indu tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Capital Reinvestment Ratio across 21 annual periods. For the full cash flow conversion analysis, see Tonghua Golden-Horse Pharmaceutical Indu cash flow conversion.
Annual Capital Reinvestment Ratio for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2025. See 000766 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥105.05 Million | CN¥64.07 Million | ▲ +101.8% |
| 2024 | 0.30x | CN¥162.75 Million | CN¥49.17 Million | ▲ +27.8% |
| 2023 | 0.24x | CN¥112.78 Million | CN¥26.67 Million | ▲ +97.4% |
| 2022 | 0.12x | CN¥198.16 Million | CN¥23.74 Million | ▼ -34.9% |
| 2021 | 0.18x | CN¥138.33 Million | CN¥25.48 Million | ▼ -22.4% |
| 2020 | 0.24x | CN¥80.71 Million | CN¥19.16 Million | ▼ -70.9% |
| 2019 | 0.81x | CN¥74.86 Million | CN¥60.98 Million | ▲ +86.9% |
| 2018 | 0.44x | CN¥170.72 Million | CN¥74.40 Million | ▼ -90.2% |
| 2017 | 4.47x | CN¥26.43 Million | CN¥118.10 Million | ▲ +139.0% |
| 2016 | 1.87x | CN¥90.63 Million | CN¥169.40 Million | ▼ -65.0% |
| 2014 | 5.34x | CN¥34.32 Million | CN¥183.39 Million | ▲ +249.0% |
| 2013 | 1.53x | CN¥102.96 Million | CN¥157.66 Million | ▲ +336.0% |
| 2010 | 0.35x | CN¥29.05 Million | CN¥10.20 Million | ▲ +113.7% |
| 2009 | 0.16x | CN¥79.94 Million | CN¥13.14 Million | ▼ -77.5% |
| 2008 | 0.73x | CN¥10.26 Million | CN¥7.48 Million | ▲ +41.6% |
| 2007 | 0.51x | CN¥9.95 Million | CN¥5.12 Million | ▲ +4.8% |
| 2005 | 0.49x | CN¥35.74 Million | CN¥17.55 Million | ▲ +115.1% |
| 2004 | 0.23x | CN¥19.12 Million | CN¥4.37 Million | ▼ -74.6% |
| 2003 | 0.90x | CN¥91.99 Million | CN¥82.57 Million | ▲ +277.1% |
| 2002 | 0.24x | CN¥72.70 Million | CN¥17.31 Million | ▼ -87.0% |
| 2000 | 1.84x | CN¥196.15 Million | CN¥360.49 Million | — |